Sacubitril/Valsartan versus enalapril in nonischemic heart failure in Paradigm-Hf trial
<p>Background: We compared the angiotensin receptor-neprilysin inhibitor LCZ696 (sacubitril/valsartan) with enalapril in patients who had nonischemic heart failure with a reduced ejection fraction. </p><p>Methods: In this double-blind trial, we randomly assigned 8442 patients with...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications,
2018-10-18.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|